Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 10 2023
Historique:
received: 16 07 2022
accepted: 20 09 2023
medline: 9 10 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: epublish

Résumé

Cancer cachexia is a complex metabolic disorder accounting for ~20% of cancer-related deaths, yet its metabolic landscape remains unexplored. Here, we report a decrease in B vitamin-related liver enzymes as a hallmark of systemic metabolic changes occurring in cancer cachexia. Metabolomics of multiple mouse models highlights cachexia-associated reductions of niacin, vitamin B6, and a glycine-related subset of one-carbon (C1) metabolites in the liver. Integration of proteomics and metabolomics reveals that liver enzymes related to niacin, vitamin B6, and glycine-related C1 enzymes dependent on B vitamins decrease linearly with their associated metabolites, likely reflecting stoichiometric cofactor-enzyme interactions. The decrease of B vitamin-related enzymes is also found to depend on protein abundance and cofactor subtype. These metabolic/proteomic changes and decreased protein malonylation, another cachexia feature identified by protein post-translational modification analysis, are reflected in blood samples from mouse models and gastric cancer patients with cachexia, underscoring the clinical relevance of our findings.

Identifiants

pubmed: 37803016
doi: 10.1038/s41467-023-41952-w
pii: 10.1038/s41467-023-41952-w
pmc: PMC10558488
doi:

Substances chimiques

Vitamin B Complex 12001-76-2
Niacin 2679MF687A
Pyridoxine KV2JZ1BI6Z
Vitamin B 6 8059-24-3
Glycine TE7660XO1C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6246

Informations de copyright

© 2023. Springer Nature Limited.

Références

Nat Commun. 2023 Apr 3;14(1):1849
pubmed: 37012289
J Cancer Res Clin Oncol. 2007 Jul;133(7):477-85
pubmed: 17356858
PLoS One. 2013 Sep 20;8(9):e75312
pubmed: 24073261
Metabolites. 2021 Dec 01;11(12):
pubmed: 34940589
PLoS Comput Biol. 2019 Dec 23;15(12):e1007569
pubmed: 31869345
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7697-E7706
pubmed: 28847964
J Immunol. 2014 Jan 1;192(1):136-44
pubmed: 24273001
PLoS Biol. 2021 Oct 26;19(10):e3001416
pubmed: 34699521
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60
pubmed: 19429898
Clin Nutr. 2014 Jun;33(3):448-58
pubmed: 23835111
Nutrients. 2019 Aug 03;11(8):
pubmed: 31382615
Jpn J Cancer Res. 1998 Jun;89(6):649-56
pubmed: 9703363
Eur J Cancer. 2006 Jan;42(1):31-41
pubmed: 16314085
Cell Metab. 2014 Dec 2;20(6):1076-87
pubmed: 25470552
J Clin Exp Hepatol. 2017 Dec;7(4):340-357
pubmed: 29234200
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Front Cell Dev Biol. 2021 Apr 29;9:664553
pubmed: 33996820
Bioinformatics. 2014 Mar 15;30(6):801-7
pubmed: 22321699
Nat Rev Cancer. 2012 Nov;12(11):741-52
pubmed: 23018234
J Biol Chem. 2006 Jun 16;281(24):16768-76
pubmed: 16608839
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Br J Cancer. 2003 Sep 15;89(6):1028-30
pubmed: 12966420
Cell Metab. 2019 Sep 3;30(3):594-606.e3
pubmed: 31257152
Nat Commun. 2022 Jun 15;13(1):3346
pubmed: 35705545
Mamm Genome. 2005 Nov;16(11):829-37
pubmed: 16284798
Cancer Res. 2022 Nov 15;82(22):4179-4190
pubmed: 36066360
Cancer Res. 1991 Dec 15;51(24):6656-9
pubmed: 1742740
Mol Metab. 2020 Nov;41:101046
pubmed: 32599075
Br J Cancer. 2002 Jun 5;86(11):1691-6
pubmed: 12087451
Proteomics. 2015 Sep;15(18):3163-8
pubmed: 25656970
J Mol Biol. 2021 Feb 19;433(4):166788
pubmed: 33387532
Nat Rev Cancer. 2018 Jan;18(1):51-63
pubmed: 29192214
Gastroenterology. 2006 Sep;131(3):900-10
pubmed: 16952558
Hepatology. 2017 Dec;66(6):2055-2065
pubmed: 28777879
Cell. 1998 Mar 6;92(5):645-56
pubmed: 9506519
Mol Cell Proteomics. 2013 Jun;12(6):1709-22
pubmed: 23436904
Cell. 2016 May 5;165(4):896-909
pubmed: 27153497
Cell Metab. 2012 Aug 8;16(2):153-66
pubmed: 22795476
Mol Syst Biol. 2015 Feb 12;11(1):784
pubmed: 25678603
Cancer Res. 2003 Nov 1;63(21):7436-42
pubmed: 14612543
PLoS One. 2015 Mar 19;10(3):e0119888
pubmed: 25789991
Cell Metab. 2015 Jun 2;21(6):805-21
pubmed: 26039447
Nat Protoc. 2009;4(7):1064-72
pubmed: 19561589
JCI Insight. 2020 May 7;5(9):
pubmed: 32298240
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Br J Cancer. 2022 Aug;127(3):379-382
pubmed: 35523879
Nature. 1970 Sep 12;227(5263):1098-103
pubmed: 5451100
Nutrients. 2018 Sep 01;10(9):
pubmed: 30200408
Anal Chem. 2016 Aug 16;88(16):7899-903
pubmed: 27436111
Clin Cancer Res. 2016 Aug 15;22(16):3999-4004
pubmed: 27340276
Am J Med. 1980 Oct;69(4):491-7
pubmed: 7424938
Nat Rev Cancer. 2014 Nov;14(11):754-62
pubmed: 25291291
Nat Rev Cancer. 2013 Aug;13(8):572-83
pubmed: 23822983
J Nutr Sci Vitaminol (Tokyo). 2016;62(2):81-7
pubmed: 27264091
Cancer Res. 2009 Jun 1;69(11):4918-25
pubmed: 19458066
Blood. 1992 May 1;79(9):2273-80
pubmed: 1571542
EMBO Rep. 2019 Apr;20(4):
pubmed: 30890538
Anal Chem. 2000 Mar 15;72(6):1236-41
pubmed: 10740865
Cancer Treat Rev. 2014 Jul;40(6):685-91
pubmed: 24321611
Genes Dev. 2016 Mar 1;30(5):489-501
pubmed: 26944676
BMJ. 1997 Nov 8;315(7117):1219-22
pubmed: 9393230
J Proteome Res. 2008 Feb;7(2):731-40
pubmed: 18183947
Ann N Y Acad Sci. 1990;585:110-7
pubmed: 2192606
Mol Cell. 2015 Jul 16;59(2):321-32
pubmed: 26073543
Physiol Rev. 2012 Oct;92(4):1515-42
pubmed: 23073625
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1487-1500
pubmed: 33006443
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Cell Metab. 2018 May 01;27(5):1067-1080.e5
pubmed: 29685734
BMJ Open Gastroenterol. 2016 Oct 18;3(1):e000097
pubmed: 27843571
Nucleic Acids Res. 2010 Jan;38(Database issue):D750-3
pubmed: 19854939
Anal Chem. 2009 Aug 1;81(15):6165-74
pubmed: 19522513
Physiol Genomics. 2020 May 1;52(5):203-216
pubmed: 32146873
PLoS Comput Biol. 2014 Dec 04;10(12):e1003926
pubmed: 25474468
Cell. 2017 May 4;169(4):651-663.e14
pubmed: 28475894
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Nature. 2015 Dec 3;528(7580):99-104
pubmed: 26632588
Physiol Rev. 2000 Jul;80(3):1107-213
pubmed: 10893433
Nat Methods. 2015 Nov;12(11):1003-4
pubmed: 26513550
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Proteome Res. 2003 Sep-Oct;2(5):488-94
pubmed: 14582645

Auteurs

Yasushi Kojima (Y)

Division of Pathophysiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. ykojima@aichi-cc.jp.

Emi Mishiro-Sato (E)

Division of Pathophysiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Teruaki Fujishita (T)

Division of Pathophysiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Kiyotoshi Satoh (K)

Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, 997-0052, Japan.

Rie Kajino-Sakamoto (R)

Division of Pathophysiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Isao Oze (I)

Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Kazuki Nozawa (K)

Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Yukiya Narita (Y)

Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Takatsugu Ogata (T)

Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Keitaro Matsuo (K)

Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Kei Muro (K)

Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

Makoto Mark Taketo (MM)

Colon Cancer Project, Kyoto University Hospital-iACT, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

Tomoyoshi Soga (T)

Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, 997-0052, Japan.

Masahiro Aoki (M)

Division of Pathophysiology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. msaoki@aichi-cc.jp.
Department of Cancer Physiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. msaoki@aichi-cc.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH